Karyopharm Therapeutics Inc. (KPTI) vs Pasithea Therapeutics Corp. (KTTA)
A side-by-side comparison of Karyopharm Therapeutics Inc. and Pasithea Therapeutics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KPTI
Karyopharm Therapeutics Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 11:26 AM EDT
Total return — KPTI vs KTTA
growth of $100 · dividends reinvested · last 5yKPTI -99.2% (-61.9%/yr)KTTA -99.4% (-63.6%/yr)KPTI compounded faster over this window
KPTI KTTA
KPTI vs KTTA: by the numbers
- •KTTA is the larger company ($15M vs $15M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -153.28% net margin).
Metrics side by side
Valuation
| Metric | KPTI | KTTA |
|---|---|---|
| P/S ratio | 0.10 | N/A |
| P/B ratio | N/A | 0.30 |
Profitability
| Metric | KPTI | KTTA |
|---|---|---|
| Gross margin | 95.88% | 0.00% |
| Operating margin | -56.17% | 0.00% |
| Net margin | -153.28% | 0.00% |
| ROE | N/A | -42.72% |
| ROIC | N/A | -48.04% |
Growth (annualized)
| Metric | KPTI | KTTA |
|---|---|---|
| Revenue CAGR (5Y) | 7.47% | N/A |
| Total return CAGR (5Y) | -62.18% | -61.48% |
Frequently asked
- How have KPTI and KTTA total returns compared?
- Over the past 5 years, KPTI delivered -62.18% and KTTA delivered -61.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.